Literature DB >> 35778845

Willingness of Older Canadians with HIV to Participate in HIV Cure Research Near and After the End of Life: A Mixed-Method Study.

David Lessard1,2,3, Karine Dubé4,5, Martin Bilodeau6, Patrick Keeler7, Shari Margolese8, Ron Rosenes8, Liliya Sinyavskaya9, Madeleine Durand9,10, Erika Benko11, Colin Kovacs11, Charlotte Guerlotté7,8, Wangari Tharao8,12,13, Keresa Arnold8,13, Renée Masching8,14,15, Darien Taylor8, José Sousa8, Mario Ostrowski15, Jeff Taylor4, Andy Kaytes4, Davey Smith4, Sara Gianella4, Nicolas Chomont16, Jonathan B Angel17, Jean-Pierre Routy1, Éric A Cohen18,19, Bertrand Lebouché1,2,3,20, Cecilia T Costiniuk1,21,22.   

Abstract

HIV cure research requires interrogating latent HIV reservoirs in deep tissues, which necessitates autopsies to avoid risks to participants. An HIV autopsy biobank would facilitate this research, but such research raises ethical issues and requires participant engagement. This study explores the willingness to participate in HIV cure research at the end of life. Participants include Canadians with HIV [people with HIV (PWHIV)] aged 55 years or older. Following a mixed-method study design, all participants completed a phone or online survey, and a subset of participants participated in in-depth phone or videoconference interviews. We produced descriptive statistics of quantitative data and a thematic analysis of qualitative data. Barriers and facilitators were categorized under domains of the Theoretical Domains Framework. From April 2020 to August 2021, 37 participants completed the survey (mean age = 69.9 years old; mean duration of HIV infection = 28.5 years), including 15 interviewed participants. About three quarters of participants indicated being willing to participate in hypothetical medical studies toward the end of life (n = 30; 81.1%), in HIV biobanking (n = 30; 81.1%), and in a research autopsy (n = 28; 75.7%) to advance HIV cure research, mainly for altruistic benefits. The main perceived risks had to do with physical pain and confidentiality. Barriers and facilitators were distributed across five domains: social/professional role and identity, environmental context and resources, social influences, beliefs about consequences, and capabilities. Participants wanted more information about study objectives and procedures, possible accommodations with their last will, and rationale for studies or financial interests funding studies. Our results indicate that older PWHIV would be willing to participate in HIV cure research toward the end of life, HIV biobanking, and research autopsy. However, a dialogue should be initiated to inform participants thoroughly about HIV cure studies, address concerns, and accommodate their needs and preferences. Additional work is required, likely through increased community engagement, to address educational needs.

Entities:  

Keywords:  HIV; HIV cure; end-of-life research; mixed-methods research; research autopsy

Mesh:

Year:  2022        PMID: 35778845      PMCID: PMC9483839          DOI: 10.1089/AID.2022.0006

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   1.723


  32 in total

Review 1.  Medical Assistance in Death as a Unique Opportunity to Advance Human Immunodeficiency Virus Cure Research.

Authors:  Teslin S Sandstrom; Stephanie C Burke Schinkel; Jonathan B Angel
Journal:  Clin Infect Dis       Date:  2019-08-30       Impact factor: 9.079

2.  International AIDS Society global scientific strategy: towards an HIV cure 2016.

Authors:  Steven G Deeks; Sharon R Lewin; Anna Laura Ross; Jintanat Ananworanich; Monsef Benkirane; Paula Cannon; Nicolas Chomont; Daniel Douek; Jeffrey D Lifson; Ying-Ru Lo; Daniel Kuritzkes; David Margolis; John Mellors; Deborah Persaud; Joseph D Tucker; Françoise Barre-Sinoussi; Galit Alter; Judith Auerbach; Brigitte Autran; Dan H Barouch; Georg Behrens; Marina Cavazzana; Zhiwei Chen; Éric A Cohen; Giulio Maria Corbelli; Serge Eholié; Nir Eyal; Sarah Fidler; Laurindo Garcia; Cynthia Grossman; Gail Henderson; Timothy J Henrich; Richard Jefferys; Hans-Peter Kiem; Joseph McCune; Keymanthri Moodley; Peter A Newman; Monique Nijhuis; Moses Supercharger Nsubuga; Melanie Ott; Sarah Palmer; Douglas Richman; Asier Saez-Cirion; Matthew Sharp; Janet Siliciano; Guido Silvestri; Jerome Singh; Bruno Spire; Jeffrey Taylor; Martin Tolstrup; Susana Valente; Jan van Lunzen; Rochelle Walensky; Ira Wilson; Jerome Zack
Journal:  Nat Med       Date:  2016-07-11       Impact factor: 53.440

Review 3.  Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021.

Authors:  Steven G Deeks; Nancie Archin; Paula Cannon; Simon Collins; R Brad Jones; Marein A W P de Jong; Olivier Lambotte; Rosanne Lamplough; Thumbi Ndung'u; Jeremy Sugarman; Caroline T Tiemessen; Linos Vandekerckhove; Sharon R Lewin
Journal:  Nat Med       Date:  2021-12-01       Impact factor: 53.440

4.  Can research at the end of life be a useful tool to advance HIV cure?

Authors:  Sara Gianella; Jeff Taylor; Timothy R Brown; Andy Kaytes; Cristian L Achim; David J Moore; Susan J Little; Ronald J Ellis; Davey M Smith
Journal:  AIDS       Date:  2017-01-02       Impact factor: 4.177

5.  Perceptions of Next-of-Kin/Loved Ones About Last Gift Rapid Research Autopsy Study Enrolling People with HIV/AIDS at the End of Life: A Qualitative Interview Study.

Authors:  Karine Dubé; Hursch Patel; Susan Concha-Garcia; Kelly E Perry; Kushagra Mathur; Sogol Stephanie Javadi; Jeff Taylor; Andy Kaytes; Brandon Brown; John A Sauceda; Susan Little; Steven Hendrickx; Stephen A Rawlings; Davey M Smith; Sara Gianella
Journal:  AIDS Res Hum Retroviruses       Date:  2020-06-25       Impact factor: 2.205

6.  Making sense of implementation theories, models and frameworks.

Authors:  Per Nilsen
Journal:  Implement Sci       Date:  2015-04-21       Impact factor: 7.327

7.  Motives for withdrawal of participation in biobanking and participants' willingness to allow linkages of their data.

Authors:  Reinder Broekstra; Judith L Aris-Meijer; Els L M Maeckelberghe; Ronald P Stolk; Sabine Otten
Journal:  Eur J Hum Genet       Date:  2021-11-22       Impact factor: 4.246

8.  Willingness to participate in HIV research at the end of life (EOL).

Authors:  Katya Prakash; Sara Gianella; Karine Dubé; Jeff Taylor; GaYoung Lee; Davey M Smith
Journal:  PLoS One       Date:  2018-07-23       Impact factor: 3.240

9.  Ethical considerations for HIV cure-related research at the end of life.

Authors:  Karine Dubé; Sara Gianella; Susan Concha-Garcia; Susan J Little; Andy Kaytes; Jeff Taylor; Kushagra Mathur; Sogol Javadi; Anshula Nathan; Hursch Patel; Stuart Luter; Sean Philpott-Jones; Brandon Brown; Davey Smith
Journal:  BMC Med Ethics       Date:  2018-10-20       Impact factor: 2.652

10.  Demographic and prosocial intrapersonal characteristics of biobank participants and refusers: the findings of a survey in the Netherlands.

Authors:  Reinder Broekstra; Judith Aris-Meijer; Els Maeckelberghe; Ronald Stolk; Sabine Otten
Journal:  Eur J Hum Genet       Date:  2020-07-31       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.